| Editorial | Financials
|
Stockholder Information
|
Headquarters
Genentech 1 DNA Way South San Francisco, California 94080-4990 (650) 225-1000 www.gene.com |
Investor Relations
Genentech invites stockholders, security analysts, representatives of
portfolio management firms and other interested parties to contact:
Katherine A. Littrell, Ph.D., R.N.
|
|
|
Stock Listing
Genentech is listed on the New York Stock Exchange under the symbol DNA.
|
Available Information
You may obtain a free copy of our annual reports on Form 10-K,
quarterly reports on Form 10-Q and current reports on Form 8-K
and amendments to those reports on the day of filing with the
Securities and Exchange Commission on our website at
www.gene.com, by calling the Genentech Investor Relations
Department at (650) 225-4150, or by sending an email message
to investor.relations@gene.com. You may also direct requests for
literature to our literature request line at (800) 488-6519.
|
|
|
Transfer Agent
Communications concerning transfer requirements, lost
certificates and change of address should be directed to
Genentech's stock transfer agent:
Computershare Trust Company, N.A.
|
Independent Registered Public Accounting Firm
Ernst & Young LLP Palo Alto, California |
|
| Annual Meeting
The annual meeting of stockholders will be held at 10:00 a.m.
Pacific Time on April 15, 2008, at the Four Seasons Hotel,
2050 University Avenue, East Palo Alto, California. Detailed
information about the meeting is contained in the Notice of
Annual Meeting and Proxy Statement sent to each stockholder
of record as of February 19, 2008.
Visit us on the web: www.gene.com. |
Other Information Genentech has included as Exhibits 31.1 and 31.2 to its 2007 Annual Report on Form 10-K filed with the Securities and Exchange Commission certifications of the chief executive officer and chief financial officer of Genentech pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, and Genentech filed with the New York Stock Exchange the Annual CEO Certification as required by Section 303A.12(a) of the New York Stock Exchange Listed Company Manual. |
